Cytokinetics Inc (NASDAQ:CYTK) traded at $43.31 at close of the session on Monday, March 10 and made a downward move of -0.28% on its previous day’s price. Cytokinetics Inc has a market cap of $5.13 billion and is expected to release its quarterly earnings report
Cytokinetics Inc (NASDAQ:CYTK) shares, rose in value on Thursday, March 06, with the stock price down by -1.39% to the previous day’s close as strong demand from buyers drove the stock to $43.27. Actively observing the price movement in the last trading, the stock closed
The trading price of Cytokinetics Inc (NASDAQ:CYTK) closed lower on Monday, March 03, and closing at $42.89, -6.76% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $75.71 and a 52-week low of
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
